Inactive Instrument

Sector Chart Genmab Nasdaq Copenhagen

Equities

Real-time Estimate Cboe Europe Other stock markets 16:00:00 28/06/2024 BST			5-day change	1st Jan Change
1,745 ^DKK	+43.39%		+4.14%	+14.24%

02:56pm	Would you like some more inflation?
11:07am	Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

	Capi.	P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED	122B
REGENERON PHARMACEUTICALS, INC.	113B
ARGENX SE	26.49B	-
BIONTECH SE	19.4B	-
BEIGENE, LTD.	15.4B	-